Precipio Inc (PRPO)

$24.02 -0.59 (-2.40%)
Market Cap 43.12M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 4,600
Avg Vol 13,780
Day's Range N/A - N/A
Shares Out 1.75M
Stochastic %K 51%
Beta 1.09
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
Cilantro5000
Cilantro5000 Dec. 5 at 3:45 PM
$PRPO
0 · Reply
eddiel
eddiel Dec. 5 at 2:59 PM
$PRPO hold
0 · Reply
Damadama
Damadama Dec. 4 at 4:05 PM
$PRPO 60 $ entro fine mese
1 · Reply
Loren77
Loren77 Dec. 4 at 2:11 PM
$PRPO DONT' WORRY https://www.stocktitan.net/news/PRPO/precipio-identifies-unauthorized-access-to-isolated-storage-no-8rom95p30ler.html
0 · Reply
Awaywithshorts
Awaywithshorts Dec. 4 at 2:01 PM
$PRPO Ignore the short narratives. They’re totally self serving
0 · Reply
houtx1
houtx1 Dec. 4 at 12:17 PM
$PRPO Many companies have specific insurance to cover data breaches, cyber attacks, and ransomware. I assume the legal dept set this up as part of business.
1 · Reply
Newbie3611
Newbie3611 Dec. 4 at 3:16 AM
$PRPO I was doing my weekly dive for articles about PRPO hoping for something good but found this instead. I really hope this doesn't kill our growth. For those who have been here for a while, you will completely understand what I am talking about. This is the exact type of thing that Ilan has used in the past to blame lackluster sales or slow new client acquisition on. Man, I don't want to hear this on the Q4 shareholder update call as his excuse. Maybe instead of Ilan using my money to buy a horse ranch he should have used it to sure up their computer security. https://botcrawl.com/precipio-data-breach/
1 · Reply
Awaywithshorts
Awaywithshorts Dec. 4 at 12:23 AM
$PRPO Look a distressed shorty
0 · Reply
jklpar72
jklpar72 Dec. 3 at 6:22 PM
$PRPO you goof balls. This company has been around forever gone through 100’s of sales people. They are tiny with tiny revenues no way this company should be a public company. Don’t waste your money. They have done several reverse splits. To stay above 1 dollar. Only reason it is trading at 20’s
4 · Reply
Love_To_Learn
Love_To_Learn Dec. 3 at 3:27 PM
$CAPR leaving metadata to $PRPO from beud courtesy of capr
0 · Reply
Latest News on PRPO
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Dec 5, 2025, 10:00 AM EST - 12 hours ago

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Dec 4, 2025, 8:00 AM EST - 1 day ago

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 17, 2025, 6:47 PM EST - 18 days ago

Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript

Precipio Announces its Q3-2025 Financial Results

Nov 14, 2025, 4:30 PM EST - 21 days ago

Precipio Announces its Q3-2025 Financial Results

Precipio Announces Q3-2025 Shareholder Update Call

Nov 4, 2025, 5:00 PM EST - 4 weeks ago

Precipio Announces Q3-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:03 PM EDT - 4 months ago

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 4 months ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 4 months ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 5 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

May 15, 2025, 6:02 PM EDT - 7 months ago

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 7 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 7 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:50 PM EDT - 8 months ago

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 9 months ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 10 months ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 11 months ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 6:16 PM EST - 1 year ago

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 1 year ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 1 year ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 5:55 PM EDT - 1 year ago

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 1 year ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 1 year ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 1 year ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 2 years ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 2 years ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 2 years ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 2 years ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 6:38 PM EST - 2 years ago

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 2 years ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:32 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 2 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 2 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Cilantro5000
Cilantro5000 Dec. 5 at 3:45 PM
$PRPO
0 · Reply
eddiel
eddiel Dec. 5 at 2:59 PM
$PRPO hold
0 · Reply
Damadama
Damadama Dec. 4 at 4:05 PM
$PRPO 60 $ entro fine mese
1 · Reply
Loren77
Loren77 Dec. 4 at 2:11 PM
$PRPO DONT' WORRY https://www.stocktitan.net/news/PRPO/precipio-identifies-unauthorized-access-to-isolated-storage-no-8rom95p30ler.html
0 · Reply
Awaywithshorts
Awaywithshorts Dec. 4 at 2:01 PM
$PRPO Ignore the short narratives. They’re totally self serving
0 · Reply
houtx1
houtx1 Dec. 4 at 12:17 PM
$PRPO Many companies have specific insurance to cover data breaches, cyber attacks, and ransomware. I assume the legal dept set this up as part of business.
1 · Reply
Newbie3611
Newbie3611 Dec. 4 at 3:16 AM
$PRPO I was doing my weekly dive for articles about PRPO hoping for something good but found this instead. I really hope this doesn't kill our growth. For those who have been here for a while, you will completely understand what I am talking about. This is the exact type of thing that Ilan has used in the past to blame lackluster sales or slow new client acquisition on. Man, I don't want to hear this on the Q4 shareholder update call as his excuse. Maybe instead of Ilan using my money to buy a horse ranch he should have used it to sure up their computer security. https://botcrawl.com/precipio-data-breach/
1 · Reply
Awaywithshorts
Awaywithshorts Dec. 4 at 12:23 AM
$PRPO Look a distressed shorty
0 · Reply
jklpar72
jklpar72 Dec. 3 at 6:22 PM
$PRPO you goof balls. This company has been around forever gone through 100’s of sales people. They are tiny with tiny revenues no way this company should be a public company. Don’t waste your money. They have done several reverse splits. To stay above 1 dollar. Only reason it is trading at 20’s
4 · Reply
Love_To_Learn
Love_To_Learn Dec. 3 at 3:27 PM
$CAPR leaving metadata to $PRPO from beud courtesy of capr
0 · Reply
imatisse
imatisse Dec. 3 at 10:22 AM
$PRPO MK M39 😲
0 · Reply
Loren77
Loren77 Dec. 2 at 6:16 PM
$PRPO We've already seen 28, so the next wave should take us to 30. No complicated reasoning. Obviously, waiting for a buyout, partnership, merge, etc., which is always possible in a microcompany that has reached financial breakeven.
0 · Reply
Awaywithshorts
Awaywithshorts Dec. 2 at 5:55 PM
$PRPO M should bs $60
0 · Reply
imatisse
imatisse Dec. 2 at 2:08 PM
$PRPO Fast track to $40
0 · Reply
shanetwomey
shanetwomey Nov. 30 at 5:22 PM
$PRPO https://open.substack.com/pub/shanetwomey/p/a-turning-point-at-precipio-inc?r=6wzdkk&utm_medium=ios
0 · Reply
eddiel
eddiel Nov. 28 at 5:39 PM
$PRPO can We spend the weekend above 25 !
0 · Reply
Investisseur55
Investisseur55 Nov. 28 at 4:31 PM
$PRPO Now that the gap at 22 has been filled on the way to 40
0 · Reply
imatisse
imatisse Nov. 28 at 9:32 AM
$PRPO came in with positive cash flow AND +30% revenue growth. Don’t Forget This -> -> “HemeScreen® Technology and Product Line singled out from thousands of products distributed by Fisher Healthcare at recent National Sales Meeting “$ #BiotechMomentum #UndervaluedRocket 🚀
0 · Reply
diddy48
diddy48 Nov. 27 at 2:52 PM
$PRPO Thermo Fisher msy have been on to something when they made this statement in 2023
0 · Reply
imatisse
imatisse Nov. 27 at 12:56 PM
$PRPO 🚀
0 · Reply
imatisse
imatisse Nov. 26 at 12:44 PM
$PRPO 🚨🧬🔥 Hey Hedge Funds, Wake Up Call! 🔥🧬🚨 $PRPO out here trading like a forgotten penny troll, but uh… Q3 came in with positive cash flow AND +30% revenue growth. That’s not “maybe turning a corner” — that’s “hey, we just found the corner and stepped on the gas”. 🏎️💨 Unique diagnostics model. Scaling revenue. ATM terminated. Translation: the dilution boogeyman left the chat. 👋👻 But hey, stay asleep if you want 😴… Retail is happy to take those early seats at the table. 🍽️😉 #PRPO #BiotechMomentum #HedgeFundWakeUp #UndervaluedRocket 🚀
0 · Reply
houtx1
houtx1 Nov. 25 at 4:19 PM
$PRPO Chart! There is a bid with 10k shares as of now at 22.00. Market makers may want to absorb those shares. There is a fair value gap around 21.50 Area(approx), that may be filled. I Would think support should begin showing up around there. JMO Posting my tboughts for a record of my analysis.
1 · Reply